AMGN (Amgen Inc)
Insider Trading Activity
Every open-market purchase and sale reported by AMGN officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-13 | Rachna Khosla | SVP, Business Development | MIXED | — | — |
| 2026-08-12 | Matthew C. Busch | VP, Finance & CAO | A | — | — |
| 2026-08-10 | Michael V Drake | Director | A | — | — |
| 2026-08-10 | CHARLES M HOLLEY | Director | A | — | — |
| 2026-08-10 | OMAR ISHRAK | Director | A | — | — |
| 2026-08-07 | Nancy A. Grygiel | SVP & CCO | MIXED | — | — |
| 2026-08-07 | Derek Miller | SVP, Human Resources | MIXED | — | — |
| 2026-08-07 | Derek Miller | SVP, Human Resources | MIXED | — | — |
| 2026-08-07 | Nancy A. Grygiel | SVP & CCO | MIXED | — | — |
| 2026-05-21 | Wanda M Austin | Director | A | — | — |
| 2026-05-21 | Michael V Drake | Director | A | — | — |
| 2026-05-21 | Brian Druker | Director | A | — | — |
| 2026-05-21 | ROBERT ECKERT | Director | A | — | — |
| 2026-05-21 | Greg C. Garland | Director | A | — | — |
| 2026-05-21 | CHARLES M HOLLEY | Director | A | — | — |
| 2026-05-21 | OMAR ISHRAK | Director | A | — | — |
| 2026-05-21 | Tyler Jacks | Director | A | — | — |
| 2026-05-21 | Mary E. Klotman | Director | A | — | — |
| 2026-05-21 | Ellen Jamison Kullman | Director | A | — | — |
| 2026-05-21 | AMY E MILES | Director | A | — | — |
| 2026-05-11 | James E. Bradner | EVP, Research and Development | F | — | — |
| 2026-05-11 | Robert A Bradway | Chairman, CEO and President | F | — | — |
| 2026-05-11 | Murdo Gordon | EVP, Global Commercial Ops | F | — | — |
| 2026-05-11 | Jonathan P Graham | EVP & Gen. Counsel & Sec. | F | — | — |
| 2026-05-11 | Peter H. Griffith | EVP & CFO | F | — | — |
| 2026-05-11 | Nancy A. Grygiel | SVP & CCO | F | — | — |
| 2026-05-11 | Rachna Khosla | SVP, Business Development | F | — | — |
| 2026-05-11 | Derek Miller | SVP, Human Resources | F | — | — |
| 2026-05-11 | DAVID M REESE | EVP & Chief Technology Officer | F | — | — |
| 2026-05-11 | Esteban Santos | EVP, Operations | F | — | — |
| 2026-05-11 | Matthew C. Busch | VP, Finance & CAO | F | — | — |
| 2026-05-07 | Michael V Drake | Director | A | — | — |
| 2026-05-07 | CHARLES M HOLLEY | Director | A | — | — |
| 2026-05-07 | OMAR ISHRAK | Director | A | — | — |
| 2026-05-07 | Esteban Santos | EVP, Operations | MIXED | — | — |
| 2026-05-07 | DAVID M REESE | EVP & Chief Technology Officer | MIXED | — | — |
| 2026-05-07 | Derek Miller | SVP, Human Resources | MIXED | — | — |
| 2026-05-07 | Rachna Khosla | SVP, Business Development | MIXED | — | — |
| 2026-05-07 | Nancy A. Grygiel | SVP & CCO | MIXED | — | — |
| 2026-05-07 | Peter H. Griffith | EVP & CFO | MIXED | — | — |
| 2026-05-07 | Jonathan P Graham | EVP & Gen. Counsel & Sec. | MIXED | — | — |
| 2026-05-07 | Murdo Gordon | EVP, Global Commercial Ops | MIXED | — | — |
| 2026-05-07 | Matthew C. Busch | VP, Finance & CAO | MIXED | — | — |
| 2026-05-07 | Robert A Bradway | Chairman, CEO and President | MIXED | — | — |
| 2026-05-07 | James E. Bradner | EVP, Research and Development | MIXED | — | — |
| 2026-05-05 | Robert A Bradway | Chairman, CEO and President | F | — | — |
| 2026-05-05 | Matthew C. Busch | VP, Finance & CAO | F | — | — |
| 2026-05-05 | Murdo Gordon | EVP, Global Commercial Ops | F | — | — |
| 2026-05-05 | Jonathan P Graham | EVP & Gen. Counsel & Sec. | F | — | — |
| 2026-05-05 | Peter H. Griffith | EVP & CFO | F | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Chairman, CEO and President | 565,220 | — |
| — | EVP, Global Commercial Ops. | 215,147 | — |
| — | EVP, Operations | 206,001 | — |
| — | EVP, Research & Development | 186,031 | — |
| — | Director | 178,669 | — |
| — | Exe VP, Global Commercial Ops | 134,606 | — |
| — | Executive V.P., Operations | 134,186 | — |
| — | EVP | 102,516 | — |
| — | Chairman of the Board and CEO | 101,018 | — |
| — | SVP, Gen. Counsel & Secy. | 95,018 | — |
| — | EVP & CFO | 94,414 | — |
| — | EVP, Operations | 83,756 | — |
| — | EVP, Operations | 79,093 | — |
| — | Director | 58,096 | — |
| — | EVP, Research & Development | 56,082 | — |
| — | SVP & CCO | 52,248 | — |
| — | EVP, Global Commercial Ops | 51,222 | — |
| — | EVP & CFO | 50,150 | — |
| — | EVP & CFO | 49,378 | — |
| — | SVP, Business Development | 45,146 | — |
| — | Director | 43,071 | — |
| — | EVP & Chief Technology Officer | 42,256 | — |
| — | Sr VP & CIO | 41,826 | — |
| — | Director | 41,674 | — |
| — | EVP, HR | 40,881 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the AMGN quote page; the site-wide leaderboard is on the insider transactions hub.